10x Genomics, Inc. TXG Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from 10x Genomics, Inc.’s reported figures.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s enterprise value?
- 10x Genomics, Inc. (TXG) reported enterprise value of $2.3B in Q1 2026.
- How has 10x Genomics, Inc.'s enterprise value changed year-over-year?
- 10x Genomics, Inc.'s enterprise value increased by 198.9% year-over-year, from $770.71M to $2.3B.
- What is the long-term trend for 10x Genomics, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s enterprise value has grown at a -35.7% compound annual growth rate (CAGR), from $15.19B to $1.67B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.